Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy

Asia-Pacific Journal of Clinical Oncology

Volumn 10, Issue 2, 2014, Pages

  Guo, Tao ^a   Yao, Fang ^a   Yang, Ai ming ^a   Li, Xiao yi ^a   Zhong, Ding rong ^a   Wu, Dong sheng ^a   Wu, Xi ^a   Lu, Xing hua ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Endoscopic ultrasound; Gastric cancer; Neoadjuvant chemotherapy; Pathological response; Restaging

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; ADVANCED CANCER; ADVANCED GASTRIC CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INFORMED CONSENT; MALE; MIDDLE AGED; PREDICTION; PRIORITY JOURNAL; RADICAL RESECTION; STOMACH CANCER; VERY ELDERLY; ADJUVANT THERAPY; COHORT ANALYSIS; ECHOGRAPHY; PATHOLOGY; PROCEDURES; STOMACH NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; ENDOSONOGRAPHY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; STOMACH NEOPLASMS;

EID: 84901621027     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12045     Document Type: Article

References (10)

1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer (NCCN). V. 2. 2009 [cited 26 October 2012 Available from: http://www.Nccn.Org/professionals/physician_gls/PDF/gastric.Pdf.
2. Park SR, Lee JS, Kim CG etal. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer 2008; 112: 2368-2376.
3. Puli SR, Reddy JBK, Bechtold ML etal. How good is endoscopic ultrasound for TNM staging of gastric cancer? A meta-analysis and systematic review. World J Gastroenterol 2008; 14: 4011-4019.
4. Yoshikawa T, Sasako M, Yamamoto S etal. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 2009; 96: 1015-1022.
5. Cunningham D, Allum WH, Stenning SP etal. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
6. Lowy AM, Mansfield PF, Leach SD etal. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999; 229: 303-308.
7. Kim SK, Kang KW, Lee JS etal. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006; 33: 148-155.
8. Bentrem D, Gerdes H, Tang L etal. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 2007; 14: 1853-1859.
9. Becker K, Mueller JD, Schulmacher C etal. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 2003; 98: 1521-1530.
10. Brenner B, Shah MA, Karpeh MS etal. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol 2006; 17: 1404-1411.